MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region

09 Oct 2024

Eisai Saudi Arabia was established in April 2024 in order to build an in-house sales system....

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Pyros Pharma announces VIGPODER™ (vigabatrin)

Avanzanite forms a Pan-European partnership with Agios to introduce PYRUKYND® for rare blood disorders

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

By ImmunoScape Pte. Ltd.
ImmunoScape Pte. Ltd.
23 Sep 2026

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

By LEVEL
LEVEL
22 Sep 2026

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

By Merck & Co., Inc.
Merck & Co., Inc.
22 Sep 2026

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

By Padagis
Padagis
21 Sep 2026

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

By StimCardio’s
StimCardio’s
21 Sep 2026

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

By Bruker Corporation
Bruker Corporation
21 Sep 2026

Most Popular

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

By Fresenius Kabi

Jul 01
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency

By Bright Gene

Jul 22
Qualia NAD+ Shown In Preliminary Clinical Study To Increase NAD+ By 85%

By Neurohacker Collective

Feb 22

September 2026

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Pyros Pharma announces VIGPODER™ (vigabatrin)

Avanzanite forms a Pan-European partnership with Agios to introduce PYRUKYND® for rare blood disorders

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Most Popular

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency

Qualia NAD+ Shown In Preliminary Clinical Study To Increase NAD+ By 85%

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter